Phio Pharmaceuticals Corp. (PHIO) › Shareholders' EquityPhio Pharmaceuticals Corp. (PHIO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2003: -$89.0K2004: -$968.0K2005: -$450.0K2006: $2.0K2007: $10.82M2008: $8.97M2009: $741.0K2010: $2.43M2011: -$587.0K2012: -$5.84M2013: $4.94M2014: $2.75M2015: $8.89M2016: $10.86M2017: $1.83M2018: $13.58M2019: $5.75M2020: $13.02M2021: $21.93M2022: $10.84M2023: $7.73M2024: $4.72M2025: $20.15M$20.15M2003Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$20.15M+326.6%2024$4.72M-38.9%2023$7.73M-28.7%2022$10.84M-50.6%2021$21.93M+68.5%2020$13.02M+126.5%2019$5.75M-57.7%2018$13.58M+640.8%2017$1.83M-83.1%2016$10.86M+22.1%2015$8.89M+223.9%2014$2.75M-44.5%2013$4.94M+184.6%2012-$5.84M-894.9%2011-$587.0K-124.2%2010$2.43M+227.9%2009$741.0K-91.7%2008$8.97M-17.1%2007$10.82M+541050.0%2006$2.0K+100.4%2005-$450.0K+53.5%2004-$968.0K-987.6%2003-$89.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share